Gefzuris (gefapixant)
- Region
- 🇪🇺 EU
- Active substance
- gefapixant
- Company
- Merck Sharp & Dohme B.V.
- Status
- Application withdrawn
- Therapeutic area
- Cough
- Application
- EMEA/H/C/005884
- ATC
- R05DB29
- Official record
- www.ema.europa.eu
Indication
Treatment of refractory or unexplained chronic cough.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Lyfnua Authorised · Merck Sharp & Dohme B.V.
Follow Gefzuris
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.